688553 汇宇制药
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资93,03567.94%55,39754,89054,3040
投资性房地产0--0000
固定资产625,148-1.94%637,532417,910299,319248,166
在建工程811,0495.55%768,425695,815365,64981,517
无形资产61,066-1.65%62,09263,51464,00836,230
商誉0--0000
其他非流动资产291,458-0.20%292,043171,175112,77086,065
1,881,7563.65%1,815,4891,403,303896,050451,977

流动资产
货币资金2,033,60814.09%1,782,4791,205,8481,305,879371,522
应收账款56,1480.36%55,94642,83311,86913,176
存货161,7055.61%153,115165,982178,86794,632
其他流动资产578,099-34.20%878,6161,458,5431,736,840281,435
2,829,560-1.41%2,870,1562,873,2063,233,455760,765

流动负债
短期借款550,30728.96%426,73245,03913,6640
应付票据0-100.00%4,106000
应付帐款121,194-6.62%129,78895,52259,24629,506
其他流动负债295,048-7.42%318,699385,833419,998367,615
966,5499.92%879,325526,394492,909397,120
流动资产净值1,863,011-6.42%1,990,8312,346,8132,740,546363,645
资产总额减流动负债3,744,767-1.62%3,806,3203,750,1163,636,596815,622

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债27,794-12.86%31,89732,04278,10064,137
27,794-12.86%31,89732,04278,10064,137

总权益
    实收股本423,6000.00%423,600423,600423,600360,000
    储备项目3,292,552-1.63%3,346,9943,294,4743,134,897391,485
股东权益3,716,152-1.44%3,770,5943,718,0743,558,497751,485
非控股权益821-78.56%3,829000